1-3 of 3
Beryl Crossley
Close
Sort by
Journal Articles

Measurable residual disease detection by high-throughput sequencing improves risk stratification for pediatric B-ALL

Clinical Trials & Observations
Brent Wood, David Wu, Beryl Crossley, Yunfeng Dai, David Williamson, Charles Gawad, Michael J. Borowitz, Meenakshi Devidas, Kelly W. Maloney, Eric Larsen, Naomi Winick, Elizabeth Raetz, William L. Carroll, Stephen P. Hunger, Mignon L. Loh, Harlan Robins, Ilan Kirsch
Journal: Blood
Blood (2018) 131 (12): 1350–1359.
https://doi.org/10.1182/blood-2017-09-806521
Published: 2018
Includes: Supplemental data
Journal Articles

Quantitative Baseline Circulating Tumor DNA Levels Correlate with GM-CSF Response to Idiotype Vaccine in Untreated Mantle Cell Lymphoma

Mark Roschewski, MD, Kieron Dunleavy, MD, Sattva S. Neelapu, MD, Stefania Pittaluga, MD PhD, Christopher Joseph Melani, MD, Elaine S. Jaffe, MD, Margaret Shovlin, RN, Beryl Crossley, BS, Katie Kong, BS, Allison Jacob, MD, Larry Kwak, Wyndham H. Wilson, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2943.
https://doi.org/10.1182/blood.V128.22.2943.2943
Published: 2016
Journal Articles

Residual Disease Monitoring By High Throughput Sequencing Provides Risk Stratification in Childhood B-ALL and Identifies a Novel Subset of Patients Having Poor Outcome

Brent L. Wood, MD PhD, David Wu, MD PhD, Ilan M. Kirsch, MD, Beryl Crossley, BS, David Williamson, Charles Gawad, MD, Michael J. Borowitz, MD PhD, Meenakshi Devidas, PhD, Kelly W. Maloney, MD, Eric Larsen, MD, Naomi Winick, MD, Elizabeth Raetz, MD, William L. Carroll, MD, Stephen P. Hunger, MD, Mignon L. Loh, MD, Harlan Robins, PhD
Journal: Blood
Blood (2016) 128 (22): 1086.
https://doi.org/10.1182/blood.V128.22.1086.1086
Published: 2016